Cologne, Germany

Michael Hubbert

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Madaus Gmbh. Active years: 2009.



 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2009

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Michael Hubbert: Innovator in Pharmaceutical Composition

Introduction

Michael Hubbert is a notable inventor based in Cologne, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of laxative compositions. His innovative approach combines effective ingredients to create a product that is both efficient and user-friendly.

Latest Patents

Michael Hubbert holds a patent for a pharmaceutical composition designed for use as a laxative. The invention focuses on a combination of senna fruit dry extract and plantago ovata seeds, which are effective in promoting bowel movements. This composition is notable for being free of guar gum, dust-free, and easily dispersible in water. Additionally, it has a pleasant taste and can be enhanced with vitamins and minerals, making it a versatile option for consumers.

Career Highlights

Throughout his career, Michael Hubbert has been associated with Madaus GmbH, a company known for its commitment to innovative pharmaceutical solutions. His work has contributed to the advancement of laxative formulations, providing effective alternatives for those in need of digestive support.

Collaborations

Michael has collaborated with esteemed colleagues such as Wolfgang Morick and Lars-Norbert Prenner. These partnerships have fostered a creative environment that encourages the development of groundbreaking pharmaceutical products.

Conclusion

Michael Hubbert's contributions to the pharmaceutical industry, particularly in laxative formulations, highlight his innovative spirit and dedication to improving health solutions. His work continues to influence the field, paving the way for future advancements in pharmaceutical compositions.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…